Can Ketogenic Diets Help PCOS? Meta-Analysis Insights

Key Takeaways (Quick Summary)

• A Clinical Nutrition meta-analysis assessed the impact of the ketogenic diet in women with PCOS.
• Short-term reductions in BMI, body weight, and waist circumference were observed.
• Insulin resistance improved, with lower fasting insulin and HOMA-IR scores.
• Lipid profiles improved, including reduced total cholesterol, LDL, and triglycerides.
• LH and testosterone decreased, while FSH remained essentially unchanged.
• Benefits were mainly linked to weight loss and improved insulin sensitivity, not ketosis alone.
• High heterogeneity and short follow-up limit conclusions on long-term outcomes.
• Evidence quality remains low, underscoring the need for larger, long-term RCTs.

Why Ketogenic Diets Are Gaining Interest in PCOS Care

Polycystic ovary syndrome (PCOS) remains the most prevalent endocrine disorder among women of reproductive age, frequently associated with insulin resistance, obesity, hyperandrogenism, and metabolic risk. Lifestyle modification, particularly weight management, continues to be a cornerstone of PCOS management.

Explore All Endocrinology and Obstetrics CME Conferences & Online Courses

The ketogenic diet, defined by very low carbohydrate intake, moderate protein, and high fat consumption, has demonstrated benefits in improving insulin sensitivity and reducing adiposity in type 2 diabetes. Given the shared metabolic pathways between diabetes and PCOS, researchers are increasingly examining whether carbohydrate restriction can support PCOS-related metabolic and hormonal outcomes.

What the Meta-Analysis Reveals About Ketogenic Diets in PCOS

The systematic review evaluated 15 studies, including randomized controlled trials and cohort studies, with 10 included in quantitative meta-analysis. Most participants had a BMI above 25 kg/m², reflecting the metabolic phenotype commonly seen in PCOS.

Does a ketogenic diet improve insulin resistance in PCOS?

Yes, pooled data showed significant reductions in HOMA-IR and fasting insulin levels following ketogenic dietary interventions, particularly among overweight individuals.

Key Clinical Findings

• Anthropometric outcomes: Significant reductions in BMI, body weight, and waist circumference
• Metabolic markers: Lower total cholesterol, LDL cholesterol, and triglycerides
• Hormonal effects: Reduced luteinizing hormone (LH) and testosterone; minimal change in FSH
• Comparative outcomes: KD showed greater weight and waist reduction than other diets, though lipid and hormonal differences were less consistent

However, outcome variability was substantial, driven by differences in study design, duration, dietary adherence, and baseline metabolic health.

Clinical Value and Practical Considerations

For clinicians managing PCOS with obesity and insulin resistance, ketogenic diets may offer short-term metabolic support, primarily mediated by weight loss rather than ketosis alone. Importantly, improvements in biochemical markers do not yet translate into strong evidence for fertility or long-term reproductive outcomes.

Is the ketogenic diet safe for long-term PCOS management?

Current evidence is insufficient. Adverse events and sustainability were inconsistently reported, and most studies lasted only weeks to a few months.

What This Means for Clinical Practice

While ketogenic diets may be considered for carefully selected PCOS patients, particularly those with metabolic dysfunction, clinicians should individualize recommendations and monitor adherence, lipid changes, and nutritional adequacy. Long-term randomized trials are essential before KD can be routinely integrated into PCOS dietary guidelines.

Source:

Clinical Nutrition Journal